Tag: FDAApprovesImetelstat
FDA Approves Imetelstat for Myelodysplastic Syndromes
Telomeres, Transfusions, and a New Drug
The FDA approved a new cancer drug on June 15, 2024. It works by attacking the very cap on the ends of human chromosome
